11 completed, 8 withdrawn, 6 unknown, 2 not yet recruiting. 30 Phase 2, 6 Phase 3, 2 Phase 1.
Follow Cryotherapy: new trials by email Literature Review of Cryotherapy trials Research Report on Cryotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts Topical 25% podophyllin, Cryotherapy - Anogenital Human Papilloma Virus Infection | Phase 2 | Not yet recruiting | Sheikh Zayed Medical College | 96 | 2025-06-29 | 2025-05-13 |
| A Randomized Controlled Trial to Evaluate the Effectiveness of Bleomycin and Cryotherapy in Treating Plantar Warts. Bleomycin injection, Cryotherapy - Verruca Plantaris | Phase 1 / Phase 2 | Recruiting | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 70 | 2024-12-25 | 2025-03-24 |
| Efficacy and Safety of Platelet-rich Plasma, Metformin and Cryotherapy in Treatment of Non-genital Warts platelet-rich plasma, Metformin, cryotherapy - Non-Genital Warts | Phase 2 / Phase 3 | Not yet recruiting | Assiut University | 108 | 2024-11-14 | 2024-11-15 |
| Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial. Intralesional Acyclovir, Cryotherapy - Plantar Wart | Phase 2 / Phase 3 | Unknown | Cairo University | 92 | 2023-10-01 | 2024-02-15 |
| Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors Cryoablation Therapy, Nivolumab, Ipilimumab - Osteosarcoma, Ewing Sarcoma | Phase 2 | Completed | Children's National Research Institute | 5 | 2022-02-18 | 2025-01-01 |
| Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer Acupuncture Therapy, Acupressure Therapy, Oral Cryotherapy - Appendix Carcinoma, Colon Carcinoma | Phase 2 | Completed | University of Washington | 78 | 2021-06-01 | 2026-01-21 |
| Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome Melphalan or Melphalan + Topotecan, etoposide, carboplatin and vincristine or local ophthalmological treatment without IV chemotherapy, Carboplatin administered on Day 1 - Retinoblastoma | Phase 2 / Phase 3 | Recruiting | Institut Curie | 225 | 2021-03-25 | 2025-11-28 |
| Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts Bleomycin Injection, Cryotherapy - Cutaneous Warts | Phase 2 | Completed | Jinnah Postgraduate Medical Centre | 154 | 2021-01-01 | 2021-08-26 |
| Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis Nivolumab 10 MG/ML Intravenous Solution [OPDIVO], Cryotherapy, Ipilimumab Injection - Melanoma (Skin) | Phase 1 / Phase 2 | Completed | University Hospital, Strasbourg, France | 19 | 2019-08-16 | 2026-06-05 |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Breast Cancer, cryotherapy - Advanced Breast Cancer | Phase 2 | Withdrawn | Fuda Cancer Hospital, Guangzhou | 2019-05-20 | 2020-10-19 | |
| Effect of Cryotherpy on Hypertrophic Scar cryotherapy (Gymna Cryoflow ICE-CT), Exercising, Positioning and splinting, Pressure Therapy and Massage - Hypertrophic Scars | Phase 2 / Phase 3 | Unknown | Zakria Mowafy | 60 | 2019-04-15 | 2020-08-31 |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Pancreatic Cancer, cryotherapy - Advanced Pancreatic Cancer | Phase 2 | Withdrawn | Fuda Cancer Hospital, Guangzhou | 2018-04-12 | 2020-10-19 | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Kidney Cancer, cryotherapy - Advanced Kidney Cancer | Phase 2 | Withdrawn | Fuda Cancer Hospital, Guangzhou | 2018-04-10 | 2020-10-19 | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Gastric cancer, Cryotherapy - Advanced Gastric Cancer | Phase 2 | Withdrawn | Fuda Cancer Hospital, Guangzhou | 2018-04-05 | 2020-10-19 | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer Activated CIK and CD3-MUC1 Bispecific Antibody in Treating colorectal cancer, Cryotherapy - Advanced Colorectal Cancer | Phase 2 | Withdrawn | Fuda Cancer Hospital, Guangzhou | 2018-04-05 | 2020-10-19 | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Lung cancer, Cryotherapy - Advanced Lung Cancer | Phase 2 | Withdrawn | Fuda Cancer Hospital, Guangzhou | 2018-03-27 | 2020-10-19 | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Liver Cancer, cryotherapy - Advanced Liver Cancer | Phase 2 | Withdrawn | Fuda Cancer Hospital, Guangzhou | 2018-03-25 | 2020-10-19 | |
| Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma Palifermin, Panobinostat, Gemcitabine - Lymphoma | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2017-06-01 | 2017-04-21 | |
| Prevention of Paclitaxel Neuropathy With Cryotherapy Cryotherapy, Paclitaxel - Breast Cancer | Phase 2 | Unknown | Medical Oncology & Hematology Associates of Northern Virginia | 39 | 2014-10-01 | 2015-10-01 |
| Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy Aminolevulinic Acid, Topical Solution Vehicle, BLU-U - Actinic Keratosis | Phase 2 | Completed | DUSA Pharmaceuticals, Inc. | 166 | 2014-09-01 | 2018-08-24 |
Showing 20 of 30. Sign in to see all of them.
Retinoblastoma (4) · Breast Neoplasms (2) · Carcinoma, Hepatocellular (2) · Keratosis, Actinic (2) · Leishmaniasis, Cutaneous (2) · Melanoma (2) · Pancreatic Neoplasms (2) · Stomach Neoplasms (2) · Adenoma, Islet Cell (1) · Anus Neoplasms (1) · Appendiceal Neoplasms (1) · Argininosuccinic Aciduria (1) · Brain Diseases (1) · Brain Edema (1) · Carbamoyl-Phosphate Synthase I Deficiency Disease (1)
Fuda Cancer Hospital, Guangzhou (7) · Almirall, S.A. (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1) · Assiut University (1) · Cairo University (1) · Children's National Research Institute (1) · DUSA Pharmaceuticals, Inc. (1) · EDAP TMS S.A. (1) · Fundacion Nacional de Dermatologia (1) · Hadassah Medical Organization (1) · Institut Curie (1) · Jinnah Postgraduate Medical Centre (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · Medical Oncology & Hematology Associates of Northern Virginia (1)
United States (9) · China (8) · Canada (2) · Egypt (2) · France (2) · Pakistan (2) · Bolivia (1) · Chile (1) · Germany (1) · India (1) · Israel (1) · Singapore (1) · Spain (1)
Jibing Chen, Doctor (7) · AeRang Kim, MD, PhD (1) · Brenda L Gallie, MD (1) · Carey Robertson, MD (1) · Carlos Rodriguez-Galindo, MD (1) · Carme Casajuana, PT (1) · Claes D Enk, MD, PhD (1) · Elise Heon, MD (1) · Ernesto Rojas, MD (1) · Helen SL Chan, MD, BS (1) · Jaime Soto, MD (1) · Jonathan Berman, MD PhD (1)
PMID 20438389, PMID 23390069, PMID 25257941, PMID 26051846, PMID 38125671, PMID 38570342
2018 (1), P30CA015704 (1)